Novo Nordisk NVO is scheduled to report fourth-quarter 2024 results on Feb. 5, 2025, before the opening bell. The Zacks ...

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

What's the most attractive weight-loss stock right now? We asked Seeking Alpha analysts Edmund Ingham, Stephen Ayers and Oneil Trader for their picks. Read more here.

J&J, AstraZeneca, Novo Nordisk and Roche are among the companies that might take a hit from the soon-to-be-enacted fees, ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Novo Nordisk. If we consider the specifics of ...

If California patients pay more than $35 per month for insulin now, it’s in large part because PBMs have rigged the system in ...

Jim Cramer, the host of Mad Money, discussed the upcoming market and corporate activity to look forward to this week, which ...

Some people are fair-weather friends; others are lifelong. It's a similar story with stocks. Some you might hold only ...

Amundi , Europe's biggest fund manager, posted in-line quarterly inflows on Tuesday, as demand for risk-averse products ...

Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals. Some, like ...

Keith Ellison said he's reached a deal with Danish pharmaceutical company Novo Nordisk to keep the cost of insulin at $35 a ...

We recently compiled a list of the 5 Stocks That Started The Year On A High. In this article, we are going to take a look at ...